“Feluda” India’s First Low Cost Covid-19 Test To Be Launched By Tata Group

Sherlock Holmes, one of the intelligent fictional characters, has the ability to find things in a nick of time. Feluda, on the other hand, is a COVID test kit which is defined to know if you are infected with Covid-19 within 30 minutes. Same concept, different criteria. One’s trust is tested, ie Sherlock, and the other one will hope so, wouldn’t force our heads down in shame.

After a long procedure, DCGI [The Drug Controller General of India] finally approved India’s first CRISPR Covid-19 test which was developed by the Tata Group and CSIR-IGIB as a partnership. TATA has manufactured a kit that will possibly detect the SARS-CoV-2 Virus genomic sequence making it change the color of the paper [in the kit] like litmus paper.

Image Source

High-quality analysis, genome editing technology CRISPR took hours of hard work and sleepless nights to introduce a product which will help with the testing speed up in the country.

Testing requires a huge number of instruments and high risk-taking factors to take samples. The doctors were most affected, even after using the face shields, masks, and gloves, there is a chance of infection. TATA then decided to work on a testing technique which followed social-distance as the first rule.

Meeting high-quality benchmarks with 96% sensitivity and 98% specificity for detecting the novel coronavirus, this kit will be launched with the utmost security and released into the market from a sanitized environment.

India, even after a decade long lockdown, is now a country with the maximum number of infected patients. A boost was the much-needed hope during this pandemic and the company has assured of providing it to the people across the country.

“Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19,” said the company.

The company called this strip as FELUDA (FnCas9 Editor Linked Uniform Detection Assay). DebojyotiChakravorty said,On the strip, you get two lines: one line is a control line which is present in every strip that is being used and tells that the strip is working fine and then there is a test line which comes positive only if the COVID-19 sequence was present in the initial RNA.”

Manoj Singh, who is another member working with the scientists  said “The main idea was given by Dr Debojyoti Chakraborty and SouvikMaiti, the senior scientists who are heading our team said that we can use these particular strips–which is already developed two years back for Sickle cell anemia–and now we are repurposing it for COVID-19 testing.”

After our Prime Minister, Mr. Narendra Modi, spoke on “ATMANIRBHAR”, it affected the vast population and hence great Indian giants, Indian technology companies have decided to work with for the country as an Atmanirbhar Indian.

TATA has therefore made it possible to stretch the testing as far as possible by developing a kit that will be affordable, reliable, accessible, and most importantly Indian in all manners.

News Source: LiveMint

Kritika
Student with ambitions, writer with ideas.
0 Shares
Tweet
Share
Pin
Share